Sage View Advisory Group, LLC Novartis Ag Transaction History

Sage View Advisory Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $401,198 - $465,341	-4,334 Reduced 61.95%	2,662 $283 Million
Q1 2024 May 08, 2024	BUY	$95.27 - $108.47 $374,315 - $426,178	3,929 Added 128.11%	6,996 $1.67 Billion
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $66,249 - $72,905	718 Added 30.57%	3,067 $331 Million
Q3 2023 Nov 02, 2023	BUY	$94.73 - $105.13 $1,042 - $1,156	11 Added 0.47%	2,349 $239 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $25,628 - $29,060	-277 Reduced 10.59%	2,338 $236 Million
Q1 2023 May 01, 2023	SELL	$80.03 - $92.81 $38,094 - $44,177	-476 Reduced 15.4%	2,615 $241 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $233,525 - $285,979	3,091 New	3,091 $280 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sage View Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sage View Advisory Group, LLC with notifications on news.